Literature DB >> 1676126

HTLV-II in patients with HTLV-I-associated myelopathy.

J Kira, Y Koyanagi, T Hamakado, Y Itoyama, N Yamamoto, I Goto.   

Abstract

Entities:  

Mesh：

Year:  1991        PMID： 1676126     DOI： 10.1016/0140-6736(91)90065-w

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  High frequencies of human T-lymphotropic virus type I (HTLV-I) infection and presence of HTLV-II proviral DNA in blood donors with anti-thyroid antibodies.

Authors:  H Mine; H Kawai; K Yokoi; M Akaike; S Saito
Journal:  J Mol Med (Berl)       Date:  1996-08       Impact factor: 4.599

2.  Co-expression of CD4 and CD8 associated with elevated interleukin-4 in a cord T cell line derived by co-cultivating normal cord leukocytes and an HTLV-II-producing simian leukocyte cell line (Si-IIA).

Authors:  K Hayashi; N Ohara; K Fujiwara; H Aoki; H J Jeon; K Takahashi; N Tomita; K Miyamoto; T Akagi
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

3.  Absence of HTLV-II co-infection in HTLV-I-associated myelopathy patients.

Authors:  K Miyamoto; T Nakamura; S Nagataki; N Tomita; K Kitajima
Journal:  Jpn J Cancer Res       Date:  1992-05

4.  HTLV-II non-integrated malignant lymphoma induction in Japanese white rabbits following intravenous inoculation of HTLV-II-infected simian leukocyte cell line (Si-IIA).

Authors:  K Hayashi; N Ohara; T R Koirala; H Ino; H L Chen; N Teramoto; E Kondo; T Yoshino; K Takahashi; M Yamada
Journal:  Jpn J Cancer Res       Date:  1994-08

5.  Southernmost carriers of HTLV-I/II in the world.

Authors:  L Cartier; F Araya; J L Castillo; V Zaninovic; M Hayami; T Miura; J Imai; S Sonoda; H Shiraki; K Miyamoto
Journal:  Jpn J Cancer Res       Date:  1993-01

6.  Human T-lymphotropic virus type II in Japan.

Authors:  H Yoshizaki; K Kitamura; A Oki; S Yahara; R Yamanaka; Y Fukushima; K Komuro; S Yamazaki; M Honda
Journal:  Jpn J Cancer Res       Date:  1996-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.